Aichi Cancer Center, Nagoya, Japan.
HPB (Oxford). 2008;10(3):183-5. doi: 10.1080/13651820801992682.
Recent progress in vascular surgical techniques has made it possible to combine liver and portal vein and/or hepatic artery (HA) or retrohepatic inferior vena cava (IVC) resection and reconstruction in cases of locally advanced cholangiocarcinoma. Reports of the success of this difficult surgery have been published. Aggressive Japanese surgeons have applied hepatopancreatoduodenectomy (HPD) not just in cases of advanced gallbladder cancer, but also in locally advanced cholangiocarcinoma with or without superficial spread. The above extended surgeries were associated with high postoperative morbidity and mortality, but recent progress in perioperative management and surgical techniques has improved the outcome of these types of surgery. Combined portal vein and liver resection provides R0 resection and contributes to longer survival in resected patients with locally advanced cholangiocarcinoma than in unresected patients. Portal vein invasion is a strong prognostic factor of cholangiocarcinoma and the actual number of 5-year survivors is limited. The number of clinical cases of liver resection combined with IVC or HA resection and reconstruction is still limited, and therefore the long-term survival benefit from these procedures has not been clarified. HPD carried high morbidity and mortality rates in the 1990s, but the outcome has been improving and an increasing number of 5-year survivors has been reported. Although the clinical value of the above extended surgeries has not been evaluated prospectively, with the increasing number of retrospective studies it has been concluded that combined liver and portal vein and/or HA or IVC resection or HPD could be indicated for selected patients with locally advanced cholangiocarcinoma.
近年来,血管外科技术的进步使得在局部晚期胆管癌患者中联合进行肝和门静脉及/或肝动脉(HA)或肝后下腔静脉(IVC)切除和重建成为可能。已经发表了成功实施这一复杂手术的报告。激进的日本外科医生不仅将肝胰十二指肠切除术(HPD)应用于晚期胆囊癌,也应用于局部晚期胆管癌伴或不伴浅表扩散。上述扩大手术与较高的术后发病率和死亡率相关,但围手术期管理和手术技术的最新进展改善了这些类型手术的结果。联合门静脉和肝切除术提供了 R0 切除,与未切除的局部晚期胆管癌患者相比,可延长切除患者的生存时间。门静脉侵犯是胆管癌的一个强烈预后因素,实际 5 年生存率有限。肝切除术联合 IVC 或 HA 切除和重建的临床病例数量仍然有限,因此这些手术的长期生存获益尚未明确。HPD 在 20 世纪 90 年代具有较高的发病率和死亡率,但手术结果一直在改善,越来越多的患者报告 5 年生存。虽然尚未前瞻性评估上述扩大手术的临床价值,但随着越来越多的回顾性研究,已经得出结论,对于局部晚期胆管癌的某些选定患者,联合肝和门静脉及/或 HA 或 IVC 切除或 HPD 可能是适应证。